Sacrococcygeal teratoma laboratory tests: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
==Overview==
==Overview==
Alpha-Fetoprotein and beta-hCG should be evaluated in patients with sacrococcygeal teratoma to determine the presence of malignant component of the tumor.<ref name = "afp">{{cite journal |vauthors=Wu JT, Book L, Sudar K |title=Serum alpha fetoprotein (AFP) levels in normal infants |journal=Pediatr. Res. |volume=15 |issue=1 |pages=50–2 |year=1981 |pmid=6163129 |doi= |url=}}</ref>
Alpha-Fetoprotein and beta-hCG should be evaluated in patients with sacrococcygeal teratoma to determine the presence of malignant component of the tumor.<ref name = "afp">{{cite journal |vauthors=Wu JT, Book L, Sudar K |title=Serum alpha fetoprotein (AFP) levels in normal infants |journal=Pediatr. Res. |volume=15 |issue=1 |pages=50–2 |year=1981 |pmid=6163129 |doi= |url=}}</ref>


==Key Laboratory Findings in Sacrococcygeal Teratoma==
==Key Laboratory Findings in Sacrococcygeal Teratoma==
*Alpha-Fetoprotein<ref name = "afp">{{cite journal |vauthors=Wu JT, Book L, Sudar K |title=Serum alpha fetoprotein (AFP) levels in normal infants |journal=Pediatr. Res. |volume=15 |issue=1 |pages=50–2 |year=1981 |pmid=6163129 |doi= |url=}}</ref>
*Alpha-Fetoprotein<ref name = "afp">{{cite journal |vauthors=Wu JT, Book L, Sudar K |title=Serum alpha fetoprotein (AFP) levels in normal infants |journal=Pediatr. Res. |volume=15 |issue=1 |pages=50–2 |year=1981 |pmid=6163129 |doi= |url=}}</ref>
*Beta-HCG
*Beta-HCG



Revision as of 16:39, 7 December 2015

Sacrococcygeal teratoma Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Sacrococcygeal teratoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sacrococcygeal teratoma laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sacrococcygeal teratoma laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sacrococcygeal teratoma laboratory tests

CDC on Sacrococcygeal teratoma laboratory tests

Sacrococcygeal teratoma laboratory tests in the news

Blogs on Sacrococcygeal teratoma laboratory tests

Directions to Hospitals Treating Sacrococcygeal teratoma

Risk calculators and risk factors for Sacrococcygeal teratoma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]

Overview

Alpha-Fetoprotein and beta-hCG should be evaluated in patients with sacrococcygeal teratoma to determine the presence of malignant component of the tumor.[1]

Key Laboratory Findings in Sacrococcygeal Teratoma

  • Alpha-Fetoprotein[1]
  • Beta-HCG

References

  1. 1.0 1.1 Wu JT, Book L, Sudar K (1981). "Serum alpha fetoprotein (AFP) levels in normal infants". Pediatr. Res. 15 (1): 50–2. PMID 6163129.

Template:WH Template:WS it:Teratoma sacro-coccigeo

Template:WikiDoc Sources